A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain

C-X-C chemokine receptor type 4 (CXCR4) is a receptor for a pleiotropic chemokine CXCL12. Previous studies have shown that the acute administration of the CXCR4 antagonist AMD3100 reduced neuroinflammation in stroke brain and mobilized bone marrow hematopoietic stem cells (HSCs). The purpose of this...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cell Transplant
Egile Nagusiak: Wu, Kuo-Jen, Yu, Seong-Jin, Shia, Kak-Shan, Wu, Chien-Huang, Song, Jen-Shin, Kuan, Hsuan-Hao, Yeh, Kai-Chia, Chen, Chiung-Tong, Bae, Eunkyune, Wang, Yun
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2017
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5661213/
https://ncbi.nlm.nih.gov/pubmed/27938478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096368916X693563
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak